Irisin inhibits dopaminergic neuron lactate metabolism and repairs mitochondrial function to alleviate Parkinson’s disease by activating SIRT1 signaling pathway
Authors:
Open Access
- 31 October 2025
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-15
Abstract
Irisin, an exercise-induced myokine with promising therapeutic potential, exhibits neuroprotective effects in Parkinson’s disease (PD). However, its underlying mechanisms remain poorly understood. This study investigated the role of irisin in an MPTP-induced mouse model of PD. Irisin treatment improved motor function, as evidenced by enhanced performance on the rotarod test, and promoted dopaminergic neuron survival, demonstrated by increased TH-positive cell counts and reduced α-synuclein accumulation. Additionally, irisin inhibited lactate metabolism in the substantia nigra by decreasing lactate and pyruvate levels and downregulating key glycolytic enzymes. Mitochondrial function was restored through reductions in oxidative stress markers and improvements in ATP synthesis and mitochondrial morphology. Furthermore, irisin activated the SIRT1 signaling pathway, leading to the deacetylation of HIF-1α and PGC-1α, which suppressed apoptosis and enhanced cell viability in MPP + -treated SH-SY5Y cells. Irisin also attenuated neuroinflammation by reducing microglial activation and protecting neurons from microglia-induced apoptosis. These findings demonstrate that irisin confers neuroprotection in PD through multiple mechanisms, including the regulation of motor function, dopaminergic neuron survival, mitochondrial function, and neuroinflammation. Activation of the SIRT1 pathway appears to be a core therapeutic target for these effects of irisin.Keywords
This publication has 42 references indexed in Scilit:
- The molecular mechanism of ferroptosis and its relationship with Parkinson's diseaseBrain Research Bulletin, 2024
- Glucose metabolism impairment in Parkinson’s diseaseBrain Research Bulletin, 2023
- Uncoupling proteins as a therapeutic target for the development of new era drugs against neurodegenerative disorderBiomedicine & Pharmacotherapy, 2022
- SIRT1 Protects Dopaminergic Neurons in Parkinson’s Disease Models via PGC-1α-Mediated Mitochondrial BiogenesisNeurotoxicity Research, 2021
- Exercise benefits on Alzheimer’s disease: State-of-the-scienceAgeing Research Reviews, 2020
- Effects of Mitochondrial Dysfunction via AMPK/PGC-1 α Signal Pathway on Pathogenic Mechanism of Diabetic Peripheral Neuropathy and the Protective Effects of Chinese MedicineChinese Journal of Integrative Medicine, 2019
- Aquarobic exercises improve the serum blood irisin and brain-derived neurotrophic factor levels in elderly womenExperimental Gerontology, 2018
- The epigenetic regulation of HIF-1α by SIRT1 in MPP + treated SH-SY5Y cellsBiochemical and Biophysical Research Communications, 2016
- BDNF and Synaptic Plasticity, Cognitive Function, and Dysfunction2014
- New insights into brain BDNF function in normal aging and Alzheimer diseaseBrain Research Reviews, 2008